Save the date! The 2026 New England Hematologic Diseases Symposium will be held on Friday, November 6.

Registration
Sponsorship

New England Hematologic Diseases Symposium

Our goal is to share best practices and to discuss complex scenarios with physicians, APPs and nurses in the New England region. With Drs. Syed Saqib Ali, Adam Boruchov, Amer Zeidan, and Sudhanshu Mulay as the Steering Committee, we have assembled a diverse faculty of renowned experts from around the country to discuss state-of-the-art therapy and the latest findings on the management of patients with hematologic malignancies and benign hematological diseases. Our goal is to share best practices and to discuss complex scenarios with physicians, APPs and nurses in the New England region. We encourage residents and fellows as well as pharmacists, research staff and other healthcare professionals interested in the field to join us.

Scientific Steering Committee

  • Adam Boruchov, MD

    Physician-in-Chief, Hartford HealthCare Cancer Institute
    Event Co-Chair

  • Amer Zeidan, MBBS, MHS

    Smilow Cancer Hospital, Yale Cancer Center
    Event Co-Chair

  • Sudhanshu B. Mulay, MD, MBBS

    Director, Anticoagulation Program, Classical Hematology Program
    Yale School of Medicine

  • Syed Saqib Ali, MBBS, MD

    Hematology Director 
    Trinity Health/ Yale Smilow Cancer Center at Saint Francis

Speakers & Topics

Hanny Al-Samkari, MD
How I Treat Chemotherapy-Induced Thrombocytopenia
Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School

Jennifer R. Brown, MD, PhD
Updates on Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute

Adam Cuker, MD, MS
How I Treat Refractory Immune Thrombocytopenia
Perelman School of Medicine, University of Pennsylvania

James D. Douketis, MD, FRCP(C), FCAHS
Managing Patients on Anticoagulants Who Need a Surgery/Procedure: What You Need to Know in 2026
McMaster University

Amy E. DeZern, MD, MHS
How I Manage Myelodysplastic Syndrome and Aplastic Anemia in 2026
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

Andrew M. Evens, DO, MBA, MSc
The Treatment of Diffuse Large B-cell Lymphoma in 2026 and Beyond
Rutgers Cancer Institute of New Jersey

Brad Kahl, MD
Update in Indolent Lymphoma
Washington University in St. Louis.

Ruben A. Mesa, MD
Pivoting to Targeted MPN Therapy
Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Muzaffar Qazilbash, MD
Sequencing CAR-T and Bispecific Antibodies in Myeloma
UT MD Anderson Cancer Center

Joshua Richter, MD, FACP
Myeloma…What to Do If It Relapses
The Tisch Cancer Institute, Mount Sinai

Saad Z. Usmani, MD, MBA, FASCO
Managing Smoldering and Newly Diagnosed Multiple Myeloma
Memorial Sloan Kettering Cancer Center

Amer Zeidan, MBBS, MHS
2026 Updates on Management of Acute Myeloid Leukemia
Smilow Cancer Hospital, Yale Cancer Center

Venue

Bristol Event Center
112 Century Drive Bristol, CT 06010